GAMCO Investors’s Pandion Therapeutics Inc. Common Stock PAND Stock Holding History

GAMCO Investors’s Portfolio PAND Stock Details PAND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-17,670	Closed	-$1.06M	–	969
2021 Q1	$1.06M	Buy	+17,670	New	+$640K	0.01%	615

GAMCO Investors's PAND Position: Q2 2021 in Review

GAMCO Investors sold out of Pandion Therapeutics Inc. Common Stock (PAND) in Q2 2021, closing a stake of 17,670 shares — an estimated $1.06M sold.

GAMCO Investors first reported a position in PAND in Q1 2021 and held it in 1 quarter. The position peaked at $1.06M in Q1 2021. 0 funds tracked by Wall St. Rank hold PAND as of Q2 2021.

GAMCO Investors reported no remaining Pandion Therapeutics Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
GAMCO Investors sold 17,670 Pandion Therapeutics Inc. Common Stock shares in Q2 2021, an estimated $1.06M.
GAMCO Investors first reported a position in Pandion Therapeutics Inc. Common Stock in Q1 2021 and held it in 1 quarter.
GAMCO Investors's Pandion Therapeutics Inc. Common Stock position peaked at $1.06M in Q1 2021.
0 funds tracked by Wall St. Rank held Pandion Therapeutics Inc. Common Stock as of Q2 2021.

Based on GAMCO Investors's 13F filing for Q2 2021, filed 13 Aug 2021.